Suppressive anti-HCV therapy for prevention of donor to recipient transmission in stem cell transplantation

American Journal of Gastroenterology

Volumn 102, Issue 2, 2007, Pages 449-451

  Surapaneni, Sri Naveen ^a   Hari, Parameswaran ^a   Knox, Josh ^a   Daniel, Jack ^a   Saeian, Kia ^a,b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZACITIDINE; BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; ERYTHROPOIETIN; PEGINTERFERON ALPHA2B; RIBAVIRIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANEMIA; ANOREXIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER REGRESSION; CASE REPORT; DISEASE TRANSMISSION; DONOR; DRUG DOSE REDUCTION; FATIGUE; GRAFT RECIPIENT; GRAFT REJECTION; HEPATITIS C; HEPATITIS C VIRUS; HLA SYSTEM; HUMAN; INFECTION PREVENTION; MALE; NAUSEA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SISTER CHROMATID; VIRUS LOAD; VIRUS TRANSMISSION;

ADMINISTRATION, ORAL; ANTIVIRAL AGENTS; DISEASE TRANSMISSION, HORIZONTAL; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPACIVIRUS; HEPATITIS C; HUMANS; INJECTIONS, SUBCUTANEOUS; INTERFERON ALFA-2B; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RIBAVIRIN; RNA, VIRAL; TRANSPLANTATION, HOMOLOGOUS;

EID: 33846547897     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2006.00937.x     Document Type: Article

References (6)

1. Zou S, Notari EP 4th, Stramer SL, et al. Patterns of age- and sex-specific prevalence of major blood-borne infections in United States blood donors, 1995 to 2002: American Red Cross blood donor study. Transfusion 2004;44:1640-7.
2. Shuhart MC, Myerson D, Childs BH, et al. Marrow transplantation from hepatitis C virus seropositive donors: Transmission rate and clinical course. Blood 1994;84:3229-35.
3. Strasser SI, Sullivan KM, Myerson D, et al. Cirrhosis of the liver in long-term marrow transplant survivors. Blood 1999;93:3259-66.
4. Peffault de Latour R, Levy V, Asselah T, et al. Long-term outcome of hepatitis C infection after bone marrow transplantation. Blood 2004;103:1618-24.
5. Socie G, Stone JV, Wingard JR, et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med 1999;341:14-21.
6. Vance EA, Soiffer RJ, McDonald GB, et al. Prevention of transmission of hepatitis C virus in bone marrow transplantation by treating the donor with alpha-interferon. Transplantation 1996;62:1358-60.